US Stock Market Movement | Novo Nordisk (NVO.US) jumps over 6% as Q3 results beat expectations and full-year guidance is raised

According to information from Zhitong Finance APP, on Wednesday, Novo Nordisk (NVO.US) rose over 6% to $42.64. According to news, on November 4, Novo Nordisk’s financial report showed that adjusted sales for the third quarter reached DKK 79.2 billion, higher than the market expectation of DKK 73.55 billion; adjusted EBIT was DKK 31.72 billion, also significantly exceeding the expected DKK 28.71 billion.